No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Express News | Biogen : Citigroup Cuts Target Price to $125 From $145
Guggenheim Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $165
Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock?
Express News | Biogen : Guggenheim Cuts Target Price to $165.00 From $168.00
Morgan Stanley Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $152